Literature DB >> 31704815

Double-negative T Cells Inhibit Proliferation and Invasion of Human Pancreatic Cancer Cells in Co-culture.

Yin Lu1, Pibo Hu2, Haibo Zhou2, Zhijian Yang3,4, Y U Sun3,4, Robert M Hoffman4,5, Jiong Chen6.   

Abstract

BACKGROUND/AIM: Double-negative T (DNT) cells are phenotypically CD3+CD4-CD8-T cells. This study aimed to investigate the anti-cancer activity of DNT cells against pancreatic cancer cells.
MATERIALS AND METHODS: DNT cells were isolated from human peripheral blood. The effect of DNT cells on proliferation and invasion of the human pancreatic cell line Panc-1 was assessed. Expression of Nrf2 and Fas in Panc-1 cells co-cultured with DNT cells was analyzed with RT-PCR. The supernatants of Panc-1 and DNT co-cultures were analyzed with ELISA for IFN-r and FasL levels.
RESULTS: The isolated DNT cell phenotype was CD4-CD8-CD56- CD3+TCR (T cell receptor) α/β+ T cells with more than 90% purity. Panc-1 cell proliferation was significantly inhibited by co-culture with DNT cells. Panc-1 cells co-cultured with DNT cells showed significantly reduced cell invasion. Panc-1 cells co-cultured with DNT cells showed increased Nrf2 and Fas mRNA expression. Increased INF-r and FasL levels were detected in the supernatants of co-cultures of DNT and pancreatic cells.
CONCLUSION: DNT cells inhibited proliferation and invasion of human pancreatic cancer cells. The INF-r, Fas/FasL pathway and Nrf2 may be involved in the anti-cancer effect of DNT cells against human pancreatic cancer. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Double-negative T cell; Nrf-2; cell proliferation invasion; pancreatic cancer

Mesh:

Substances:

Year:  2019        PMID: 31704815     DOI: 10.21873/anticanres.13795

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Phenotypical and Functional Characterization of Cytotoxic Unconventional T-Cells.

Authors:  Margherita Gigante; Elena Ranieri
Journal:  Methods Mol Biol       Date:  2021

Review 2.  TCRαβ+ CD4-/CD8- "double negative" T cells in health and disease-implications for the kidney.

Authors:  Andrea M Newman-Rivera; Johanna T Kurzhagen; Hamid Rabb
Journal:  Kidney Int       Date:  2022-04-09       Impact factor: 18.998

Review 3.  DNT Cell-based Immunotherapy: Progress and Applications.

Authors:  Yingrui Li; Kang Dong; Xueke Fan; Jun Xie; Miao Wang; Songtao Fu; Qin Li
Journal:  J Cancer       Date:  2020-03-31       Impact factor: 4.207

Review 4.  CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.

Authors:  Zhiheng Wu; Yu Zheng; Jin Sheng; Yicheng Han; Yanyan Yang; Hongming Pan; Junlin Yao
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

5.  Renieramycin T Inhibits Melanoma B16F10 Cell Metastasis and Invasion via Regulating Nrf2 and STAT3 Signaling Pathways.

Authors:  Baohua Yu; Jing Liang; Xiufang Li; Li Liu; Jing Yao; Xiaochuan Chen; Ruijiao Chen
Journal:  Molecules       Date:  2022-08-22       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.